Cargando…

Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study

Background: It remains unclear what B cell and humoral responses are mounted by chronic kidney disease (CKD) patients in response to recombinant and inactivated SARS-CoV-2 vaccines. In this study, we aimed to explore the cellular and humoral responses, and the safety of recombinant and inactivated S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Siliang, He, Jiaoxia, Tang, Bin, Zhou, Qin, Hu, Yudong, Yu, Yuan, Chen, Jianwei, Liu, Yi, Li, Chunmeng, Ren, Hong, Liao, Xiaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918183/ https://www.ncbi.nlm.nih.gov/pubmed/36769873 http://dx.doi.org/10.3390/jcm12031225

Ejemplares similares

An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
por: Zhang, Haili, et al.
Publicado: (2022)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

561. Recombinant Adenovirus Carrying Spike Gene Induces Effective Humoral and Cellular Immunity Against SARS-CoV in Rats
Publicado: (2004)

Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease
por: Chen, Zhiwei, et al.
Publicado: (2022)

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice
por: Barroso, Shana P. C., et al.
Publicado: (2015)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
por: Zhao, Wen-Man, et al.
Publicado: (2022)

Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
por: Zhu, Qian, et al.
Publicado: (2022)

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
por: Li, Ziwei, et al.
Publicado: (2021)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Cellular and humoral immune response to recombinant Escherichia coli OmpA in cows
por: Rainard, Pascal, et al.
Publicado: (2017)

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
por: Pleyer, Christopher, et al.
Publicado: (2022)

Novel Inactivated Subtype B Avian Metapneumovirus Vaccine Induced Humoral and Cellular Immune Responses
por: Bao, Yuanling, et al.
Publicado: (2020)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients
por: da Silva, Laís Teodoro, et al.
Publicado: (2021)

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
por: Mohn, Kristin G.-I., et al.
Publicado: (2022)

Humoral and Cellular Immune Response to Sars-Cov-2 Vaccination in Patients with Chronic GVHD
por: Manjappa, Shivaprasad, et al.
Publicado: (2022)

Longitudinal survey of humoral and cellular response to SARS-CoV-2 infection in children
por: Ruedas-López, Alba, et al.
Publicado: (2022)

The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
por: Xiang, Tiandan, et al.
Publicado: (2022)

Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM
por: Konishi, Yoshinobu, et al.
Publicado: (2022)

Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease
por: Nagant, Carole, et al.
Publicado: (2019)

Immuno-modulatory Effects of Inactivated Dietzia Maris on the Selected Aspects of Cellular and Humoral Immune Responses in Mice
por: Nofouzi, Katayoon, et al.
Publicado: (2023)

Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population
por: Li, Jiwei, et al.
Publicado: (2022)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

Cellular and humoral immunity in patients infected with the SARS-CoV-2 virus at general hospital
por: Brandão, Valéria, et al.
Publicado: (2021)

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
por: Chu, Chang, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity
por: Pasoto, Sandra Gofinet, et al.
Publicado: (2022)

Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model
por: de Castro Barbosa, Emerson, et al.
Publicado: (2022)

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
por: Wang, Ji, et al.
Publicado: (2022)

Corrigendum to “Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population”
por: Li, Jiwei, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
por: Chen, Zhonghao, et al.
Publicado: (2022)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gauem3k822o0o0pnjogr6jsnot